Trace elements, heavy metals and vitamin levels in patients with coronary artery disease

International Journal of Medical Sciences

Volumn 8, Issue 6, 2011, Pages 456-460

  Cebi, Aysegul ^a   Kaya, Yuksel ^b   Gungor, Hasan ^c   Demir, Halit ^d   Yoruk, Ibrahim Hakki ^d   Soylemez, Nihat ^b   Gunes, Yilmaz ^d   Tuncer, Mustafa ^d  

^a GIRESUN UNIVERSITY   (Turkey)

^b Department of Cardiology   (Turkey)

^c Mus State Hospital   (Turkey)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Heavy metal; Trace element; Vitamin

Indexed keywords

ALPHA TOCOPHEROL; CADMIUM; COLECALCIFEROL; COPPER; CREATININE; HEAVY METAL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LEAD; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE; RETINOL; TRACE ELEMENT; VITAMIN; ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEMOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRON BLOOD LEVEL; LEAD BLOOD LEVEL; PATHOGENESIS; RISK FACTOR; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

EID: 80052054578     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.456     Document Type: Article

References (41)

1. Yusoff K. Vitamin E in cardiovascular disease: Has the diet been cast? Asia Pac J Clin Nutr. 2002; 11: 443-447.
2. Gey KF, Puska J, Jordon P, et al. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991; 53: 326-334.
3. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci. 1993; 90: 7915-7922.
4. Steinberg D. Anti-oxidant vitamins and coronary heart disease. N Engl J Med. 1993; 328: 1487-1489.
5. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res. 1999; 40: 227-238.
6. Adams AK, Wermuth EO, Mcbride PE. Antioxidant vitamins and the prevention of coronary heart disease. Am Fam Physician. 1999; 60: 895-904.
7. Yavuz B, Ertugrul DT, Cil H, et al. Increased Levels of 25 Hy-droxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvas-tatin Treatment: A Novel Pleiotropic Effect of Statins? Cardio-vasc Drugs Ther. 2009; 20: 312-320.
8. Tuomainen TP, Punnonen K, Nyyssonen K, et al. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation. 1998; 97: 1461-1466.
9. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation. 1999; 99: 852-854.
10. Miller KW and Yang CS. An Isocratic High-Performance Liquid Chromatography Method for the Simultaneous Analysis of Plasma Retinol, α-tocopherol and Various Carotenoids. Anal Biochem. 1985; 145: 21-26.
11. Zaspel BJ, and Csallany S. Determination of Alpha-Tocopherol in Tissues and Plasma by High-Performance Liquid Chromatography. Anal Biochem. 1983; 130: 146-150.
12. Reynolds SL and Judd HJ. Rapid Procedure for the Determination of Vitamins A and D in Fortified Skimmed Milk Powder Using High-Performance Liquid Chromatography. Anal Biochem. 1984; 109: 489-492.
13. Kagan A, Kannel WB, Dawber TR, et al. The coronary profile. Ann Ny Acad Sci. 1963; 97: 883-894.
14. Reunanen A, Knekt P, Marniemi J, et al. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr. 1996; 50: 431-437.
15. Lukaski HC, Klevay LM, Milne DB. Effects of dietary copper on human autonomic cardiovascular function. Eur J Appl Physiol. 1988; 58: 74-80.
16. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981; 1: 1293-1294.
17. Ascherio A, Willett WC, Rimm EB, et al. Dietary iron intake and risk of coronary disease among men. Circulation. 1994; 89: 969-974.
18. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med. 1994; 330: 1119-1124.
19. Ascherio A, Willett WC, Rimm EB, et al. Blood donations and risk of coronary heart disease in men. Circulation. 2001;103: 52-57.
20. Reunanen A, Takkunen H, Knekt P, et al. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med. 1995; 238: 223-230.
21. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol. 1994; 139: 704-712.
22. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328: 1450-1456.
23. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005; 293:1338-47.
24. Kanabrocki EL, Scheving LE, Olwin JH, et al. Circadian variation in the urinary excretion of electrolytes and trace elements in men. Am J Anat. 1983; 166: 121-148.
25. Volkov NF. The cobalt, manganese and zinc content in the blood and internal organs of atherosclerotic patients. Ter Arkh. 1962; 34: 52-56.
26. Bala Iu M, Plotko SA, Furmenko G. Content of manganese, nickel, zinc, copper, silver and lead in the blood, aorta, liver, kidneys and pancreas of atherosclerotic patients. Ter Arkh. 1967; 39: 105-111.
27. Masironi R. Trace elements and cardiovascular diseases. Bull World Health Organ. 1969; 40: 305-312.
28. Kromhout D. Blood lead and coronary heart disease risk among elderly men in Zutphen the Netherlands. Environ Health Per-spect. 1988; 78: 43-46.
29. Navas-Acien A, Guallar E, Silbergeld EL, et al. Lead Exposure and Cardiovascular Disease-A Systematic Review. Environ Health Perspect. 2007; 115: 472-482.
30. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002; 162: 2443-2449.
31. Rock E, Winklhofer-Roob BM, Ribalta J, et al. Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr Metab Cardiovasc Dis. 2001; 11: 70-73.
32. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of acombination of β-carotene and vitamin A on lung cancer and cardiovascular disease. NEJM. 1996; 334: 1150-1155.
33. Riccioni G, Bucciarelli T, Mancini B, et al. Antioxidant Vitamin Supplementation in Cardiovascular Diseases. Ann Cli Lab Sci. 2007; 37: 12-16.
34. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998; 351: 805-806.
35. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation. 2008; 117: 503-511.
36. Carrie W, Nemerovski PD, Michael P, et al. Vitamin D and Cardiovascular Disease. Pharmacotherapy. 2009; 29: 691-708.
37. Lind L, Hanni A, Lithell H, et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995; 8: 894-901.
38. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997; 96: 1755-1760.
39. Doherty TM, Tang W, Dascalos S, et al. Ethnic origin and serum levels of 1,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation. 1997; 96: 1477-1481.
40. Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990; 19: 559-563.
41. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure. J Am Coll Cardiol. 2003; 41: 105-112.